Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Fundamental Analysis of Aarti Drugs Limited

About the Company - Aarti Drugs Limited

Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2251.17 Cr. and Equity Capital is Rs. 92.60 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot No. 198, M.I.D.C., Tarapur, Palghar District Maharashtra 401506investorrelations@aartidrugs.com
http://www.aartidrugs.com
Management
NamePosition Held
Mr. Chandrakant V GogriChairman Emeritus
Mr. Prakash M PatilChairman & M.D & CEO
Mr. Rashesh C GogriManaging Director
Mr. Harshit M SavlaJoint Managing Director
Mr. Harit P ShahExecutive Director
Mr. Uday M PatilExecutive Director
Mr. Neha R GadaNon Executive Director
CA. Navin C ShahIndependent Director
Dr. Krishnacharya G AkamanchiIndependent Director
Prof. Bhaskar N ThoratIndependent Director
CA. Priti P SavlaIndependent Director

Aarti Drugs Ltd. Share Price Update

Share PriceValue
Today₹491.45
Previous Day₹485.95

Basic Stock Data of Aarti Drugs Limited

Market Cap 4,494 Cr.
Current Price 485
High / Low646/311
Stock P/E27.4
Book Value 120
Dividend Yield0.21 %
ROCE15.3 %
ROE14.6 %
Face Value 10.0

Aarti Drugs Limited Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales515472452506511593641551625626696592578
Expenses406374374432442503557496555557608520512
Operating Profit109987874699184557069897265
OPM %21%21%17%15%14%15%13%10%11%11%13%12%11%
Other Income0412121001111
Interest7544556789888
Depreciation12121212121212121212121212
Profit before tax90856360537567365049695347
Tax %23%24%21%24%24%26%21%28%27%25%23%25%26%
Net Profit70655046415653263737534035
EPS in Rs7.496.945.394.924.396.035.722.853.953.965.744.273.73

Aarti Drugs Limited Quarterly Chart

Aarti Drugs Limited Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales6598269721,0871,0761,0891,1401,4541,6351,9152,2512,4982,491
Expenses5797038229159009109551,2521,3871,5111,9302,2122,196
Operating Profit80123150172176179185203248404321286295
OPM %12%15%15%16%16%16%16%14%15%21%14%11%12%
Other Income2-011041697523
Interest25313742473836413626233633
Depreciation24262831363738404748474747
Profit before tax32668610093108112128175338256205218
Tax %30%31%28%22%29%30%35%32%22%24%24%25%
Net Profit2245627866757387136258195153164
EPS in Rs2.324.676.388.016.847.917.789.2514.5627.6521.0616.5017.70
Dividend Payout %27%27%26%41%25%3%3%3%3%9%5%6%

Aarti Drugs Limited Profit & Loss Yearly Chart

Aarti Drugs Limited Growth

Compounded Sales Growth
10 Years::12%
5 Years::17%
3 Years::15%
TTM::3%

Aarti Drugs Limited Growth

Compounded Profit Growth
10 Years::13%
5 Years::16%
3 Years::6%
TTM::-5%

Aarti Drugs Limited Growth

Stock Price CAGR
10 Years::35%
5 Years::28%
3 Years::-15%
1 Year::7%

Aarti Drugs Limited Growth

Return on Equity
10 Years::22%
5 Years::22%
3 Years::22%
Last Year::15%

No data available for the Balance Sheet data table.

Aarti Drugs Limited Reserves and Borrowings Chart

Aarti Drugs Limited Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 4472951071251746214719615440162
Cash from Investing Activity -48-58-105-102-87-96-71-59-29-69-125-131
Cash from Financing Activity 3-1611-5-37-789-87-168-8584-31
Net Cash Flow-0-22-11-0-01-1-0-11

Aarti Drugs Limited Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days100951041031099311711010496115117
Inventory Days809571778710113286107125120102
Days Payable778884758591125861109410389
Cash Conversion Cycle10310191105110103124109101127133130
Working Capital Days105101909710810312810895118132130
ROCE %14%20%22%21%18%17%17%17%20%33%21%15%

Aarti Drugs Limited Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Aarti Drugs Limited Shareholding Pattern Chart

No. of Aarti Drugs Limited Shareholders

Aarti Drugs Limited Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Quant Business Cycle Fund3410002.4916.01
Quant Healthcare Fund1410004.16.62
Nippon India Nifty Smallcap 250 Index Fund194480.130.91
ICICI Prudential Nifty Smallcap 250 Index Fund45580.140.25
HDFC NIFTY Smallcap 250 ETF20810.140.11
HDFC Nifty Smallcap 250 Index Fund16130.140.09
ICICI Prudential S&P BSE 500 ETF2990.010.02
HDFC S&P BSE 500 ETF160.010
HDFC S&P BSE 500 Index Fund410.010

Aarti Drugs Limited ROCE Trend

Aarti Drugs Limited EPS Trend

Aarti Drugs Limited Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)17.9722.1230.0960.5738.48
Diluted EPS (Rs.)17.9722.1230.0960.5738.48
Cash EPS (Rs.)23.4027.5435.4481.6156.11
Book Value[Excl.RevalReserv]/Share (Rs.)128.80111.9198.00280.04230.45
Book Value[Incl.RevalReserv]/Share (Rs.)128.80111.9198.00280.04230.45
Revenue From Operations / Share (Rs.)293.31268.75231.20775.14661.92
PBDIT / Share (Rs.)33.2436.8047.38113.0088.96
PBIT / Share (Rs.)27.8131.3942.0392.0870.91
PBT / Share (Rs.)24.2129.1539.5979.5255.56
Net Profit / Share (Rs.)17.9722.1430.0960.6938.06
NP After MI And SOA / Share (Rs.)17.9622.1430.0960.6938.06
PBDIT Margin (%)11.3313.6920.4914.5713.43
PBIT Margin (%)9.4711.6818.1811.8710.71
PBT Margin (%)8.2510.8417.1210.258.39
Net Profit Margin (%)6.128.2313.017.825.74
NP After MI And SOA Margin (%)6.128.2313.017.825.74
Return on Networth / Equity (%)13.9419.7830.6921.6716.51
Return on Capital Employeed (%)17.2922.9233.4622.5419.34
Return On Assets (%)6.869.2815.878.966.16
Long Term Debt / Equity (X)0.170.130.160.270.38
Total Debt / Equity (X)0.500.510.330.510.86
Asset Turnover Ratio (%)1.171.181.191.121.05
Current Ratio (X)1.601.481.771.451.33
Quick Ratio (X)1.050.921.080.920.90
Inventory Turnover Ratio (X)3.393.373.153.893.68
Dividend Payout Ratio (NP) (%)5.564.518.304.942.62
Dividend Payout Ratio (CP) (%)4.273.637.053.671.78
Earning Retention Ratio (%)94.4495.4991.7095.0697.38
Cash Earning Retention Ratio (%)95.7396.3792.9596.3398.22
Interest Coverage Ratio (%)9.2516.4219.247.815.25
Interest Coverage Ratio (Post Tax) (%)6.0010.8813.205.063.15
Enterprise Value (Cr.)3725.824488.496770.511508.911976.21
EV / Net Operating Revenue (X)1.371.803.140.831.27
EV / EBITDA (X)12.1013.1715.335.739.42
MarketCap / Net Operating Revenue (X)1.151.603.010.650.96
Retention Ratios (%)94.4395.4891.6995.0597.37
Price / BV (X)2.623.837.091.812.78
Price / Net Operating Revenue (X)1.151.603.010.650.96
EarningsYield0.050.050.040.110.05

Aarti Drugs Limited Profitability Ratios (%)

Aarti Drugs Limited Liquidity Ratios

Aarti Drugs Limited Liquidity Ratios (%)

Aarti Drugs Limited Interest Coverage Ratios (%)

Aarti Drugs Limited Valuation Ratios

Fair Value of Aarti Drugs Limited Stock

Fair Value: ₹481.06

The stock is overvalued by 0.81% compared to the current price ₹485

*Investments are subject to market risks

Strength and Weakness of Aarti Drugs Limited Stock

Unable to fetch valid data for stock valuation.

More Stocks